Financial Research & Reports Finder | ResearchPool

Almost there...

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

First Name*

Last Name*

Country*

Email*

Password* ( 6 or more alphabetic and numerical characters )

Get financial insights straight to your inbox

YES

Do you want to use these details for invoicing

I have read and accept ResearchPool Terms & Conditions, and Privacy Policy, including our Cookie Use Policy

Already on ResearchPool? Login Now

LOGIN

Email

Password

This combination of email and password didn't match our records. Your account might not be activated. If so, please click on the link we sent you via email. You can also request a password reset or a new activation email using the links below.

Forgot password | Resend activation email

New to ResearchPool? Register Now

Register |
Login

English

View

FILTERS (0)

CATEGORY

INDUSTRY/SECTOR

GEOGRAPHY

COMPANY

MARKET CAP

PROVIDER * Not connected to ResearchPool

ANALYST

REPORT TYPE

TAGS

MORE FILTERS

RECOMMENDATION

ACCESS TYPE

NUMBER OF PAGES

LANGUAGE

KEYWORDS

DATE RANGE

reports

Arnaud Riverain

Arnaud Riverain

EGIDE - Avenant aux accord de crédit - Achat - Obj. 1,78 € - Pot. +105...

Avenant aux accord de crédit

06/20/22 June 20, 2022 4 FR

Arnaud Riverain

Arnaud Riverain

UNITI - Résultats 2021 + Augmentation de capital : Opinion : Achat ...

Croissance organique supérieure à nos attentes compensant une contribution de Première Pierre inférieure à nos anticipations ; Renforcement des fonds propres de 7,98 M€ via une augmentation de capital ; Backlog de 980 M€ à fin 2021, soit 5 650 logements à livrer sur 3 ans.

06/02/22 June 2, 2022 5 FR

Loïc Wolf

Loïc Wolf

MILIBOO - CA 2021/22: CA T4 -14,1%, inférieur aux attentes- - Opinion:...

CA T4 en baisse : 9,3 M€, -14,1% - Inférieur à nos attentes CA 12 mois : 39,2 M€, -4,3% Perspectives : limiter le repli des marges

06/01/22 June 1, 2022 4 FR

Arnaud Riverain

Arnaud Riverain

CAPELLI - CA 2021-22 : Entre deux eaux - Achat - 29€ vs 32,4 € - Poten...

CA 2021-22 de 290,3 M€ +3,5% vs 316,4 M€ attendus ; Backlog 605 M€ vs 722 M€ attendu ; CA 2022-23 attendu supérieur à 350 M€.

05/25/22 May 25, 2022 4 FR

Loïc Wolf

Loïc Wolf

ADUX - CA T1: +35% - Confiance pour 2022 - Opinion: Achat - Objectif: ...

Forte croissance au T1 CA de 5,5 M€, +35% Confiance pour 2022

05/20/22 May 20, 2022 4 FR

Loïc Wolf

Loïc Wolf

M2i - CA T1: +8,6% - Croissance interne forte pour 2022 - Opinion: Ach...

CA T1 de 11,8 M€, +8,6% Croissance interne forte pour 2022

05/13/22 May 13, 2022 4 FR

Arnaud Riverain

Arnaud Riverain

PHA Pharmagest Inte...

EQUASENS - CA T1 : Pharmagest devient EQUASENS - Achat - Obj. 112,7 € ...

CA T1 +9% à 49,4 M€ (+7% à périmètre constant).

PHA PHARMAGEST INTERACTIVE SA

05/13/22 May 13, 2022 4 FR

Loïc Wolf

Loïc Wolf

PROL PROLOGUE SA

PROLOGUE - CA T1: +13,4% - Très bonne dynamique attendue pour 2022 - O...

CA T1 de 25 M€, +13,4% Très bonne dynamique attendue pour 2022

05/13/22 May 13, 2022 4 FR

Loïc Wolf

Loïc Wolf

ADOMOS: Lancement d'une augmentation de capital - Opinion & Objectif S...

Lancement d’une augmentation de capital par ABSA avec maintien du DPS Objectif de lever 2,3 M€ Intentions de souscription représentant 81,5% de l’offre

05/10/22 May 10, 2022 4 FR

Arnaud Riverain

Arnaud Riverain

DLTA Delta Plus Grou...

DELTA PLUS - CA T1 - En avance sur nos prévisions - Achat - Obj. 109,6...

CA groupe +21,8% à 99,2 M€ ; CA Europe 54,2 M€ +30,8% (+6,5% pc et tcc) ; CA hors Europe 45 M€ +12,5% (+2,8% pc et tcc) ; Impact de change +1,9 M€.

DLTA DELTA PLUS GROUP SA

05/06/22 May 6, 2022 4 FR

Arnaud Riverain

Arnaud Riverain

SOG SOGECLAIR SA

SOGECLAIR - CA T1 : 4ème trimestre consécutif de croissance à 2 chiffr...

CA T1 +16,8% - 33,6 M€ Engineering 17,8 M€ +14,5% Solutions 15,7 M€ +18,9% Conseil 0,09 M€ International 15,9 M€ +16,2%

05/05/22 May 5, 2022 4 FR

Loïc Wolf

Loïc Wolf

M2i: Résultats 2021 - Supérieurs aux attentes - Opinion: Achat - Objec...

ROC de 2 M€, +143,3% RN de 0,5 M€ vs -0,1 M€ en 2020 Perspectives de croissance et d’amélioration des résultats

05/02/22 May 2, 2022 4 FR

Loïc Wolf

Loïc Wolf

PROL PROLOGUE SA

Prologue: Roc de 1,9 M€, +36% - Supérieur aux attentes - Opinion: Acha...

ROC de 1,91 M€, +36% RN Corrigé de -0,3 M€ vs 0 M€ en 2020 Perspectives de croissance et d’amélioration des résultats

05/02/22 May 2, 2022 4 FR

Loïc Wolf

Loïc Wolf

ALTBG Blockchain Grou...

BLOCKCHAIN GROUP : Résultats 2021 - Croissance de 10% mais repli des m...

Croissance de 10% des produits d’exploitations Les marges se rétractent du fait des forts investissements en R&D Perspectives toujours positives

ALTBG BLOCKCHAIN GROUP SA

05/02/22 May 2, 2022 4 FR

Loïc Wolf

Loïc Wolf

MINT: RN 2021 - Pertes moins élevées que prévues - Intégration de Plan...

Pertes moins élevées que prévues REX 2021 : -2 M€ vs -4,3 M€ estimé / RN : -2,3 M€ vs 4,3 M€ estimé Intégration de Planète Oui

05/02/22 May 2, 2022 4 FR

Arnaud Riverain

Arnaud Riverain

ALSAF Safe Orthopaedi...

SAFE / Résultats 2021 : L'intégration de Safe Medical paie - Opinion ...

Marge brute +17,7 points à 56,7% (45,8% attendue) ; ROC -7,65 M€ vs -6,67 M€ (-7,1 M€ attendu) ; RN -6,7 M€ vs -8,3 M€ (-7,7 M€ attendu).

ALSAF SAFE ORTHOPAEDICS SAS

05/02/22 May 2, 2022 4 FR

Loïc Wolf

Loïc Wolf

MLREW ReWorld Media S...

REWORLD - Nouveau renforcement de l'offre - Opinion: Achat - Objectif:...

Renforcement à venir de l’offre Psychologies et Bien-être

MLREW REWORLD MEDIA SA

04/25/22 April 25, 2022 4 FR

Loïc Wolf

Loïc Wolf

ALINV Invibes Adverti...

INVIBES - CA T1: 5,77 M€, +67,4% - Opinion: Achat - Objectif: 30,10 € ...

CA T1 de 5,77 M€, +67,4% Perspectives toujours bien orientées

ALINV INVIBES ADVERTISING

04/21/22 April 21, 2022 4 FR

Arnaud Riverain

Arnaud Riverain

ALSAF Safe Orthopaedi...

SAFE / CA T1 + Visite de site : Opinion : Achat Spéculatif - Obj. 0,4...

CA T1 +31% (1 418 K€) Ventes Directes +34% (585 K€) ; Ventes Indirectes +33% (343 K€) ; Safe Medical +26% (490 K€) ; Trésorerie au 31 mars : 652 K€.

ALSAF SAFE ORTHOPAEDICS SAS

04/15/22 April 15, 2022 4 FR

Loïc Wolf

Loïc Wolf

ADUX - Résultats 2021: Résultat net positif, une 1ère depuis 2014 - Op...

Résultat net positif, une première depuis 2014 ! RN de 0,24 M€ vs -0,9 M€ en 2021

04/08/22 April 8, 2022 4 FR

Loading...

New interest

Save your current filters as a new Interest

Name your interest: Please enter a name for this interest

No Label

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Name your search: Please enter a name for this saved search

No Label

Email alerts

Would you like to receive real-time email when a new report matches this search?

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Email*

Password* ( 6 or more characters )

Get financial insights straight to your inbox

Do you want to use these details for invoicing

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool? Sign in

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

Do you want to use these details for invoicing

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool? Sign in

Email

Password

Forgot your password?

New to ReseearchPool? Sign-up

Unfortunately, this report is not available for the investor type or country you selected.

Report is subscription only.

Thank you, your report is ready.

Thank you, your report is ready.

Copyright © 2017 ResearchPool. All Rights Reserved

About Us
Blog
Press
FAQs
Terms & Conditions
Privacy Policy
Mediation

Copyright © 2017 ResearchPool. All Rights Reserved

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

Access premium insights from a wide range of providers on one convenient platform
Easily search, browse and choose exactly the research that you want to consume
Get unbundled research at competitive prices –separate from dealing commissions and other ancillary services

How to subscribe

Contact us to get started on your subscription

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

Access premium insights from a wide range of providers on one convenient platform
Easily search, browse and choose exactly the research that you want to consume
Get unbundled research at competitive prices –separate from dealing commissions and other ancillary services

How to subscribe

Contact us to get started on your subscription